Ferrer PA, Ramos VJ, Vargas GS, López SA, Trujillo AL, Medina RBA, Pérez SCA, Otero RD

Language: Spanish
References: 12
Page: 78-86
PDF size: 260.14 Kb.

ABSTRACT

A female patient of 70 years old, personal medical history of bronchial asthma, high blood pressure and diabetes mellitus type 2 with chronic renal failure, stage V secondary to this, multiple entries in hospital by developing respiratory sepsis and need for peritoneal dialysis. It was found giant splenomegaly in imaging study during one of the entries. She evolved unfavorably with hypotension, fever, diffuse abdominal pain. The pathological findings showed a lymphoma of small lymphocytes/chronic lymphocytic leukemia cells. Stage IV. With infiltration to multiple viscera, including: lymph nodes, liver, spleen, lung, kidney and serous .The presence of pseudofoliculos is considered a morphological feature almost absolutely pathognomonic of the disease.

REFERENCES

1. Harris NL, Campo E, Jaffe ES, Pileri SA. Introduction to the WHO classification of tumors of haematopoietic and lymphoid tissues. En: Swerdlow S, editors. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC; 2008. p. 14-15.

2. Romero-Guadarrama MB, Hernández-González MM, Durán- Padilla MA, Mandujano- Álvarez G, Alcántara-Vásquez A. Linfoma B difuso de células grandes. Características patológicas y de inmunofenotipo en 148 pacientes estudiados en el Hospital General de México. Rev Med Hosp Gen Mex. 2009;69(4):192-198.

3. Jayasekara H, Karahalios A, Juneja S, Thursfield V, Farrugia H, English DR, et al. Incidence and survival of lymphohematopoietic neoplasms according to the World Health Organization classification: a population-based study from the Victorian Cancer Registry in Australia. Leuk Lymphoma [Internet]. 2010 [citado 10 Ene 2013];51(3):[aprox. 3 p.]. Disponible en: http://www.tandfonline.com/doi/abs/10.3109/10428190903552104

4. Kumar V, Abbas AK, Aster JC. Hematopoietic and lymphoid systems. En: Robbins basic pathology. 9th ed. Philadelphia: Elsevier; 2013. p.407-458.

5. Byrd JC, Gribben JG, Peterson BL, Grever MR, Lozanski G, Lucas DM, et al. Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy. J Clin Oncol [Internet]. 2006 [citado 21 Ene 2013];24(3):437-43. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/16344317

6. Valk P, Meijer C. Hematopoietic system. Lymph nodes. En: Mills SE, editors. Histology for pathologists. 3rd ed. Nueva York: Lippincott Williams & Wilkins; 2007. p. 765-83.

7. Rosai J. Rosai and Ackerman's surgical pathology. 10th ed. New York: Elsevier; 2011.

8. Kumar V, Abbas AK, Fausto N, Aster JC. Enfermedades de los leucocitos, ganglios linfáticos, bazo y timo. En: Robbins y Cotran patología estructural y funcional. 8va ed. España: Elsevier; 2010. p. 589-638.

9. Martin D, Randy G. Molecular biology, pathology and cytogenetics of chronic lymphocytic leukemia. En: Clinical malignant hematology. New York: McGraw-Hill; 2007. p. 213-25.

10. Gorczyca W. Mature B-cell neoplasms. En: Atlas of differential diagnosis in neoplastic hematopathology. 2nd ed. New York: Informa Healthcare; 2008. p. 120-217.

11. Basquiera A, Márquez M, Vijnovich A, Picon A, Zerga M. Linfoma difuso de células grandes B [Internet]. 2012 [citado 28 Mar 2013]. Disponible en: http://webcache.googleusercontent.com/search?q=cache:RXH5oOAdDGQJ:sah.org.ar/docs/251274.5B.SAH_GUIA2012_LinfomaCelulasGrandes_1.pdf+&cd=2&hl=es&ct=clnk&gl=cu

12. Sánchez B, García JF, Sánchez M. Advances in classical hodgkin lymphoma biology: new prognostic factors and outcome prediction using gene expression signatures. En: Hodgkin's lymphoma. Croatia: In Tech; 2012. p. 29-33.